Sudden glory revisited: Cognitive contents of hypomania

Psychotherapy and Psychosomatics

Volumn 76, Issue 5, 2007, Pages 278-288

  Colom, Francesc ^a   Vieta, Eduard ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Bipolar disorders; Cognition; Hypomania; Overinclusion

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ARTICLE; BEHAVIOR; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTION; GENETIC POLYMORPHISM; HUMAN; HYPOMANIA; KNOWLEDGE; NEUROCHEMISTRY; PHILOSOPHY; PRIORITY JOURNAL; PROGNOSIS; PSYCHODYNAMICS; PSYCHOTHERAPY; SOCIOLOGY; THINKING; THOUGHT DISORDER;

AFFECT; BIPOLAR DISORDER; COGNITION DISORDERS; HUMANS; INSTINCT; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGICAL THEORY; THINKING;

EID: 34547912508     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104704     Document Type: Article

References (83)

1. Colom F, Martínez-Arán A, Vieta E: Uselessness of psychotherapy in bipolar disorders: short review and happy end; in Vieta E (ed): Bipolar Disorders: Clinical and Therapeutic Progress. Barcelona, Panamericana, 2001.
2. Vieta E, Gastó C, Martínez-de-Osaba MJ, Nieto E, Cantó TJ, Otero A, Vallejo J: Prediction of depressive relapse in remitted bipolar patients using corticotropin-releasing hormone challenge test. Acta Psychiatr Scand 1997;95:205-211.
3. Vieta E, Martínez-de-Osaba MJ, Colom F, Martínez- Arán A, Benabarre A, Gastó C: Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients. Psychol Med 1999;29:971-978.
4. 99mTc-HMPAO SPECT in depressed bipolar I patients. Psychiatry Res 2004;132:285-289.
5. Benabarre A, Vieta E, Martinez-Aran A, Garcia-Garcia M, Martin F, Lomena F, Torrent C, Sanchez-Moreno J, Colom F, Reinares M, Brugue E, Valdes M: Neuropsychological disturbances and cerebral blood flow in bipolar disorder. Aust NZ J Psychiatry 2005;39:227-234.
6. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK: Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977;134:1227-1233.
7. Andreasen NC: A unitary model of schizophrenia: Bleuler's 'fragmented phrene' as schizencephaly. Arch Gen Psychiatry 1999;56:781-787.
8. Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Gasto C, Salamero M: Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000;69:2-18.
9. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK: Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004;72:29-39.
10. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR: Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 2004;56:301-307.
11. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR: A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005;31:5-19.
12. Colom F, Vieta E, Martínez-Arán A, Reinares M, Benabarre A, Gastó C: Clinical factors associated to treatment non-compliance in euthymic bipolar patients. J Clin Psychiatry 2000;61:549-554.
13. Scott J: Using health belief models to understand the efficacy-effectiveness gap for mood stabilizer treatments. Neuropsychobiology 2002;46(suppl 1):13-15.
14. Colom F, Vieta E: A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disord 2004;6:480-486.
15. Vieta E, Colom F: Psychological interventions in bipolar disorder: from wishful thinking to an evidence-based approach. Acta Psychiatr Scand 2004;422(suppl):34-38.
16. Scott J, Colom F: Psychosocial treatments for bipolar disorders. Psychiatr Clin North Am 2005;28:371-384.
17. Perry A, Tarrier N, Morris R, McCarthy E, Limb K: Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999;318:149-153.
18. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003;60:402-407.
19. Colom F, Vieta E, Reinares M, Martinez-Aran A, Torrent C, Goikolea JM, Gasto C: Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. J Clin Psychiatry 2003;64:1101-1105.
20. Lam DH, Hayward P, Watkins ER, Wright K, Sham P: Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. Am J Psychiatry 2005;162:324-329.
21. Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M: Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262-270.
22. Mendel E: Die Manie - Eine Monographie. Wien, Urban & Schwarzenberg, 1881.
23. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W: Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003;73:133-146.
24. Vieta E, Gastó C, Otero A, Nieto E, Vallejo J: Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997;38:98-101.
25. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R: Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(suppl 1):S5-S30.
26. Benazzi F: Is 4 days the minimum duration of hypomania in bipolar II disorder? Eur Arch Psychiatry Clin Neurosci 2001;251:32-34.
27. Kirmayer LJ, Groleau D: Affective disorders in cultural context. Psychiatr Clin North Am 2001;24:465-478.
28. Angst J: The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143-151.
29. Géraud M: Emil Kraepelin et la bipolarité: invention ou dépassement? Encéphale 1997;suppl 1:12-19.
30. Abraham K: Notes on the psycho-analytical investigation and treatment of manic-depressive insanity and allied conditions (1912); in Bryan D, Strachey A (transl): Selected Papers on Psychoanalysis. London, Hogarth Press, 1927.
31. Freud S: Duelo y melancolía; in Freud S: Obras Completas. Madrid, Biblioteca Nueva, 1922.
32. Lewin BD: The Psychoanalysis of Elation. New York, Norton, 1950.
33. Bley NF: Denial in fantasy and hypomania: an exploration. J Am Psychoanal Assoc 1984;32:865-879.
34. Garno JL, Goldberg JF, Ramirez PM, Ritzler BA: Impact of childhood abuse on the clinical course of bipolar disorder. Br J Psychiatry 2005;186:121-125.
35. Grof S:Psicología transpersonal: nacimiento, muerte y trascendencia en psicoterapia. Barcelona, Kaidós, 1994.
36. Beck AT: Cognitive Theory and the Emotional Disorders. New York, International Universities Press, 1976, pp 47-132.
37. Winters K, Neale J: Mania and low self-esteem. J Abnorm Psychol 1985;94:282-290.
38. Lyon HM, Startup M, Bentall RP: Social cognition and the manic defense: attributions, selective attention, and self-schema in bipolar affective disorder. J Abnorm Psychol 1999;108:273-282.
39. Lam D, Wong H: Prodromes, coping strategies, insight and social functioning in bipolar affective disorders. Psychol Med 1997;27:1091-1100.
40. Murphy FC, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES, Sahakian BJ: Decision-making cognition in mania and depression. Psychol Med 2001;31:679-693.
41. Scott J, Stanton B, Garland A, Ferrier IN: Cognitive vulnerability in patients with bipolar disorder. Psychol Med 2000;30:467-472.
42. Jones L, Scott J, Haque S, Gordon-Smith K, Heron J, Caesar S, Cooper C, Forty L, Hyde S, Lyon L, Greening J, Sham P, Farmer A, McGuffin P, Jones I, Craddock N: Cognitive style in bipolar disorder. Br J Psychiatry 2005;187:431-437.
43. Scott J: Psychotherapy for bipolar disorder: an unmet need? Br J Psychiatry 1995;167:581-588.
44. Colom F, Vieta E, Martínez A, Jorquera A, Gastó C: What is the role of psychotherapy in the treatment of bipolar disorders? Psychother Psychosom 1998;67:3-9.
45. Post RM, Roy-Byrne PP, Uhde TW: Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988;145:844-848.
46. Power M, Dalgleish T: Cognition and Emotion: From Order to Disorder. Hove, Psychology Press, 1997.
47. Leahy RL, Beck AT: Cognitive therapy of depression and mania; in Georgotas A, Cancro R (eds): Depression and Mania. New York, Elsevier, 1988.
48. Schou M: The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand 1995;95:361-363.
49. Ghaemi SN, Stoll AL, Pope HG Jr: Lack of insight in bipolar disorder: the acute manic episode. J Nerv Ment Dis 1995;183:464-467.
50. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text rev. Washington, American Psychiatric Association, 2000.
51. Beck AT, Rush AJ, Shaw B, Emery G: Cognitive Therapy of Depression. New York, Wiley & Sons, 1979.
52. Piddington R: The Psychology of Laughter. New York, Gamut Press, 1963.
53. McDougall W: Some General or Non-Specific Innate Tendencies - An Introduction to Social Psychology, rev ed. Boston, Luce & Co, 1926, pp 93-124.
54. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL: The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002;71:651-655.
55. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES: Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002;7:579-593.
56. Tsai SJ: Is mania caused by overactivity of central brain-derived neurotrophic factor? Med Hypotheses 2004;62:19-22.
57. Vollenweider FX, Maguire RP, Leenders KL, Mathys K, Angst J: Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res 1998;83:149-162.
58. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, DSM IV. Washington, American Psychiatric Association, 1994.
59. Goodwin FK, Jamison R: Manic-Depressive Illness. New York, Oxford University Press, 1990.
60. Panksepp J: Affective Neuroscience: The Foundations of Human and Animal Emotions. New York, Oxford University Press, 1998.
61. Heath RG: Electrical self-stimulation of the brain in man. Am J Psychiatry 1963;120:571-577.
62. Quaade F, Vaernet K, Larson S: Stereotaxic stimulation and electrocoagulation of the lateral hippocampus in obese humans. Acta Neurochir 1974;30:111-117.
63. Zuckerman M, Buchsbaum MS, Murphy DL: Sensation seeking and its biological correlates. Psychol Bull 1980;88:187-214.
64. Zuckerman M: Sensation Seeking: Beyond the Optimal Level of Arousal. Hillsdale, Erlbaum Associates, 1979.
65. Cronin C, Zuckerman M: Sensation seeking and bipolar affective disorder. Pers Individ Diff 1992;13:385-387.
66. Cassidy F, McEvoy JP, Yang YK, Wilson WH: Insight is greater in mixed than in pure manic episodes of bipolar I disorder. J Nerv Ment Dis 2001;189:398-399.
67. Rossi A, Daneluzzo E, Arduini L, Di Domenico M, Stratta P, Petruzzi C: Cognitive symptoms of mania in pure and mixed episodes evaluated with the Positive and Negative Syndrome Scale. Eur Arch Psychiatry Clin Neurosci 2000;250:254-256.
68. Pallanti S, Quercioli L, Pazzagli A, Rossi A, Dell'Osso L, Pini S, Cassano GB: Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry 1999;156:1094-1096.
69. Martinez-Aran A, Vieta E, Colom F, Torrent C, Reinares M, Goikolea JM, Benabarre A, Comes M, Sanchez-Moreno J: Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom 2005;74:295-302.
70. Balanza-Martinez V, Tabares-Seisdedos R, Selva-Vera G, Martinez-Aran A, Torrent C, Salazar-Fraile J, Leal-Cercos C, Vieta E, Gomez-Beneyto M: Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 2005;74:113-119.
71. Chambers JR, Windschitl PD, Suls J: Egocentrism, event frequency, and comparative optimism: when what happens frequently is 'more likely to happen to me'. Pers Soc Psychol Bull 2003;29:1343-1356.
72. Barrantes-Vidal N, Colom F, Claridge G: Temperament and personality in mood disorders; in Vieta E (ed): Bipolar Disorders: Clinical and Therapeutic Challenges. Madrid, Panamericana, 2001.
73. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M, Clayton P, Goodwin F: Switching from 'unipolar' to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995;52:114-123.
74. Cameron N: Experimental analysis of schizophrenic thinking;in Kasanin JS (ed): Language and Thought in Schizophrenia. Berkeley, University of California Press, 1944.
75. Andreasen NJ, Powers PS: Overinclusive thinking in mania and schizophrenia. Br J Psychiatry 1974;125:452-456.
76. Klein DN: Overinclusion and manic symptomatology in schizophrenics. J Clin Psychol 1982;38:44-51.
77. Jampala VC, Taylor MA, Abrams R: The diagnostic implications of formal thought disorder in mania and schizophrenia: a reassessment. Am J Psychiatry 1989;146:459-463.
78. Healy D, Williams JM: Moods, misattributions and mania: an interaction of biological and psychological factors in the pathogenesis of mania. Psychiatr Dev 1989;7:49-70.
79. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-1088.
80. Vieta E, Calabrese JR, Hennen J, Colom F, Martinez-Aran A, Sanchez-Moreno J, Yatham LN, Tohen M, Baldessarini RJ: Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry 2004;65:1420-1428.
81. Vieta E: Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Hum Psychopharmacol 2005;20:225-236.
82. Calabrese JR, Keck PE, Macfadden W, Mikwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J, the Bolder Study Group: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-1360.
83. Corrigan P, Wallace C, Green M: Cognitive dysfunction and psychosocial skill learning in schizophrenia. 144th Annu Meet Am Psychiatr Assoc, New Orleans, 1991.